Navigation Links
Swiss Biotech Gnubiotics, Announces Global Launch of GNU100 the First Microbiome Specialty Ingredient for Companion Animal Gut Health
Date:4/12/2019

Gnubiotics Sciences SA is a Swiss biotech company pioneering the development of products from complex microbiota accessible carbohydrates (MACs) as specialty ingredients for the global animal and human nutrition markets.

Gnubiotics announced its listing in the EU Feed Materials Register and commercial launch of its first-in class microbiome modulating prebiotic GNU100, for companion animal gut health. Gnubiotics’ GNU100 MAC is registered in Europe as an oligosaccharide-peptide complex with the objective to enhance microbiota restoration. As a result of its activity on specific commensals in the microbiome, GNU100 will also be studied to act as a weight control modulator.

GNU100 comprises of at least 30 different oligosaccharide structures that are functional mimics of Human Milk Oligosaccharides (HMOs). HMOs are oligosaccharides found naturally in animal and human breast milk and are key to the early development and maintenance of the immune system.

At Vitafoods Europe, Gnubiotics will host a presentation by Prof. Kelly Swanson of the University of Illinois-Urbana Champaign, titled “Modulatory Activity of Microbiota Accessible Carbohydrates” which will highlight GNU100 in vivo palatability data as well as the in vitro activity of GNU100 on key microbes beneficial to companion animal health Lactobacillus acidophilus, Akkermansia muciniphila and Bacteroides thetaiotaomicron.

“The global launch of GNU100 marks a milestone in our commitment to bringing the benefits of our pipeline of functional HMO mimics to companion animals,” said JP Kunz, CEO at Gnubiotics.

Through the combination of advanced high-precision chemistry and genomic technologies, Gnubiotics aims to expand nutritional solutions, to meet consumer expectations for effective, natural and healthier foods and supplements for their companion animal.

To learn more about how GNU100 can benefit your consumers, please visit Gnubiotics Sciences at Vitafoods Europe in Geneva Palexpo, May 7 – 9, 2019, at booth #K85
StartLab / Biopôle, Route de la Corniche, 5, Bat. SE-B Page 1 of 2 CH-1066 Epalinges

Media contact information – Gnubiotics Sciences SA. Jean Philippe Kunz, CEO Email: jpkunz(at)gnubiotics.com

Read the full story at https://www.prweb.com/releases/swiss_biotech_gnubiotics_announces_global_launch_of_gnu100_the_first_microbiome_specialty_ingredient_for_companion_animal_gut_health/prweb16240237.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Swiss cheese crystal, or high-tech sponge?
2. Jessica Wein Joins Lifecycle Biotechnologies As Marketing Strategist
3. Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space
4. Lifecycle Biotechnologies Announces Promotion of Cindy Baptiste to Business Development Manager
5. Lifecycle Biotechnologies Releases Company Catalog
6. Lifecycle Biotechnologies Launches 100-Liter SAFEthread Drum
7. Avastus Opens New Vivarium to Serve the Preclinical Research Needs of Boston’s Biotech Community
8. Biotech Automation and FDA Validation Expert Superior Controls to Exhibit and Recruit at the ISPE Annual Premier One-Day Biopharmaceutical Show on September 26
9. Dickinson Wright Attorney Lance Anderson Named Pharmaceuticals and Biotechnology Practice Group Chair
10. William Muzek joins Lifecycle Biotechnologies as Business Development Manager
11. Venture Fund with Key Focus on Alzheimers Announces Investment in M3 Biotechnology and Its Drug Aimed at Regrowing Brain Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2019)... ... August 02, 2019 , ... Bioclinica, a ... in advancing the development of medical therapies, announced today that Michael O’Neal, M.D., ... one of the “100 Most Inspiring People in the Life-Sciences Industry.” Dr. ...
(Date:8/1/2019)... ... 31, 2019 , ... Advancements with Ted Danson to focus ... information. , Factor Bioscience Inc. (Factor) is pioneering nucleic-acid and cell-based technologies to ... segment of Advancements will explore how Factor Bioscience is building the future of ...
(Date:7/23/2019)... ... July 23, 2019 , ... ... genetic counseling, today announced that the company has expanded its database of genetic ... familial hypercholesterolemia (FH), and Parkinson’s disease. , The expanded content comes following 23andMe’s ...
Breaking Biology News(10 mins):
(Date:7/2/2019)... Calif. (PRWEB) , ... July 02, 2019 , ... Leading ... documentary entitled Animal Pharm: Where Beasts Meet Biotech. The film focuses on regenerative ... wild animals. Animal Pharm was recently included in the Brentwood and ...
(Date:6/18/2019)... N.J. (PRWEB) , ... June 17, 2019 , ... ... announced that they have entered into an agreement for production and manufacturing of ... for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for ...
(Date:6/12/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... June ... ... premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, ... partnership agreement with Shanghai Zillion has been signed. The agreement will grant exclusive ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local listings for ... will educate viewers about how its technology facilitates laboratories to improve efficiency and ...
Breaking Biology Technology: